PURCHASE ORDER
Active75D30126P21238
Department of Health and Human Services › Centers for Disease Control and Prevention › CDC OFFICE OF ACQUISITION SERVICES
$234K
obligated · signed 2 months ago
INTEGRASE INHIBITOR LAT FLOW DEVICES - EO 14398
Performance timeline
Start
Aug 19, 2026
End
Oct 20, 2027
with all options
Loading status
Estimated start: Oct 20, 2026
BEACON SCIENTIFIC INC
Contract 75D30126P21238
UEI
DP2PZHVMDKL4
Parent Company
BEACON SCIENTIFIC INC
Capabilities & Certifications
Headquarters Location
Congressional District: 51
Current Obligation
$234,000
Base + Exercised Options
$234,000
Total Ceiling Value
$234,000
Contract Type
FIRM FIXED PRICE
NAICS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Place of Performance
Congressional District: 51
Awarding Agency
Top-tier agency
Centers for Disease Control and Prevention
Sub-tier agency
CDC OFFICE OF ACQUISITION SERVICES
Office
Funding Agency
Top-tier agency
Centers for Disease Control and Prevention
Sub-tier agency
CDC OFFICE OF ACQUISITION SERVICES
Office
Solicitation procedures, competition exceptions, labor standards and account totals.